Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.0B | 3.0B | 3.0B | 3.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 329M | 422M | 322M | 334M |
| Other operating expenses | 54M | 18M | 18M | 18M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.6B | 1.5B | 1.6B | 1.7B |
| Tax provision | 373M | 338M | 368M | 381M |
| Net income | 1.2B | 1.1B | 1.3B | 1.3B |
| Basic EPS | 0.4 | 0.3 | 0.4 | 0.4 |
| Diluted EPS | 0.4 | 0.3 | 0.4 | 0.4 |
| Basic average shares | 314.5M | 321.5M | 320.5M | 320.9M |
| Diluted average shares | 317.4M | 321.5M | 320.5M | 320.9M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.6B | 1.5B | 1.6B | 1.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 26M | — | — | — |